Cat. No. | Product Name | Field of Application | Chemical Structure |
---|---|---|---|
DC9279 | MK-571 Featured |
MK-571 is a selective, orally active CysLT1 receptor antagonist.
More description
|
![]() |
DC40870 | Etalocib Featured |
Etalocib (LY293111), an orally active leukotriene B4 receptor antagonist, inhibits the binding of [3H]LTB4, with a Ki of 25 nM. Etalocib (LY293111) prevents LTB4-induced calcium mobilization with an lC50 of 20 nM. Etalocib (LY293111) induces apoptosis.
More description
|
![]() |
DC73452 | LY290154 |
LY290154 is a leukotriene LTD4/E4 antagonist.
More description
|
![]() |
DC3160 | Montelukast Sodium Featured |
Montelukast belongs to a group of medications known as leukotriene receptor antagonists.
More description
|
![]() |
DC71777 | Montelukast dicyclohexylamine |
Montelukast (MK0476) dicyclohexylamine is a potent, selective and orally active antagonist of cysteinyl leukotriene receptor 1 (CysLT1). Montelukast dicyclohexylamine can be used for the reseach of asthma and liver injury. Montelukast dicyclohexylamine also has an antioxidant effect in intestinal ischemia-reperfusion injury, and could reduce cardiac damage. Montelukast dicyclohexylamine decreases eosinophil infiltration into the asthmatic airways. Montelukast dicyclohexylamine can also be used for COVID-19 research.
More description
|
![]() |
DC71336 | Chamazulene |
Chamazulene, a natural compound, is an antioxidant-type inhibitor of leukotriene B4 formation.
More description
|
![]() |
DC71156 | SR2640 hydrochloride Featured |
SR2640 (hydrochloride) is a potent and selective competitive leukotriene D4/leukotriene E4 antagonist. SR2640 can be used for researching the role of leukotrienes in human asthma.
More description
|
![]() |
DC70980 | U-75302 |
U-75302 is a potent inhibitor of leukotriene B4. U-75302 is a pyridine analogue. U-75302 has the potential for the research of inflammatory diseases.
More description
|
![]() |
DC49641 | BAY-u 9773 |
BAY-u 9773 is a non-selective antagonist of the CysLT receptors (cysteinyl leukotrienes receptors) with about the same IC50 for CysLT1 and CysLT2. BAY-u9773 is used for the inhibition of LT responses.
More description
|
![]() |
DC49640 | REV 5901 |
REV 5901 is a competitive and orally active antagonist of leukotriene receptor, with a Ki of 0.7 μM. REV 5901 is also a 5-lipoxygenase inhibitor. REV 5901 can be used for the research of asthma in which leukotriene release be involved.
More description
|
![]() |
DC49073 | Ablukast |
Ablukast (Ro 23-3544) is a specific and active leukotriene receptor antagonist. Ablukast effectively reduces LTC4- and antigen-induced bronchoconstriction. Ablukast is LTD4 receptor antagonist.
More description
|
![]() |
DC48998 | Verlukast |
Verlukast is a potent, selective, and orally active antagonist of leukotriene receptor. Verlukast has the potential for the research of asthma.
More description
|
![]() |
DC48160 | Masilukast |
Masilukast is an orally administered cysteinyl leukotriene D4 (LTD4) receptor antagonist with potential to treat asthma.
More description
|
![]() |
DC28814 | (S)-Verapamil hydrochloride Featured |
(S)-Verapamil hydrochloride (S(-)-Verapamil hydrochloride) inhibits leukotriene C4 (LTC4) and calcein transport by MRP1. (S)-Verapamil hydrochloride leads to the death of potentially resistant tumor cells.
More description
|
![]() |
DC47101 | γ-Linolenic acid ethyl ester |
γ-Linolenic acid ethyl ester (Ethyl γ-linolenate) is a leukotriene B4 receptor 4 (LTB4) antagonist.
More description
|
![]() |
DC46461 | CAY10583 |
CAY10583 is a potent and selective full Leukotriene B4 receptor type 2 (BLT2) agonist. CAY10583 directly promotes keratinocyte migration in vitro and accelerates wound closure in vivo. CAY10583 is a promising pharmaceutical agent for diabetic wounds.
More description
|
![]() |
DC45359 | 12S-HHT |
12S-HHT (12(S)-HHTrE) is an enzymatic product of prostaglandin H2 (PGH2) derived from cyclooxygenase (COX)-mediated arachidonic acid metabolism. 12S-HHT is an endogenous ligand for BLT2 that fully activates BLT2 in vivo. 12S-HHT suppresses UV-induced IL-6 synthesis in keratinocytes, exerting an anti-inflammatory activity.
More description
|
![]() |
DC40767 | (S)-Verapamil D7 hydrochloride |
(S)-Verapamil D7 hydrochloride ((S)-(-)-Verapamil D7 hydrochloride) is a deuterium labeled (S)-Verapamil hydrochloride. (S)-Verapamil hydrochloride (S(-)-Verapamil hydrochloride) inhibits leukotriene C4 (LTC4) and calcein transport by MRP1. (S)-Verapamil hydrochloride leads to the death of potentially resistant tumor cells.
More description
|
![]() |
DC40582 | Montelukast |
Montelukast is a potent, selective and orally active antagonist of cysteinyl leukotriene receptor 1 (CysLT1). Montelukast can be used for the reseach of asthma and liver injury. Montelukast also has an antioxidant effect in intestinal ischemia-reperfusion injury, and could reduce cardiac damage.
More description
|
![]() |
DC28289 | HAMI 3379 |
HAMI 3379 is a potent and selective Cysteinyl leukotriene (CysLT2) receptor antagonist. HAMI 3379 has a protective effect on acute and subacute ischemic brain injury, and attenuates microglia-related inflammation.
More description
|
![]() |
DCAPI1015 | Zafirlukast(Accolate) |
Zafirlukast(Accolate)
More description
|
![]() |
DC7472 | Nedocromil |
Nedocromil is an inhaled anti-inflammatory agent for the preventive management of asthma.
More description
|
![]() |
DC10935 | HAMI3379 |
HAMI3379 (HAMI-3379) is a potent and selective antagonist of cysteinyl leukotriene 2 (CysLT(2)) receptor, inhibits LTD4- and LTC4-induced intracellular calcium mobilization withIC50 of 3.8 nM and 4.4 nM respectively.
More description
|
![]() |
DC12342 | Gemilukast (ONO-6950) |
Gemilukast is an orally active and potent dual cysteinyl leukotriene 1 and 2 receptors (CysLT1 and CysLT2) antagonist, with IC50s of 1.7, 25 nM for human CysLT1 and CysLT2, respectively.
More description
|
![]() |